Subscribe to RSS
DOI: 10.1055/s-2004-824904
Noninvasive Aspergillus Pulmonary Disease
Publication History
Publication Date:
19 April 2004 (online)
Noninvasive Aspergillus pulmonary disease may be the result of a host response to Aspergillus antigens or colonization of the lung with Aspergillus species. The prototype example of each of these phenomena are allergic bronchopulmonary aspergillosis and aspergilloma. Allergic bronchopulmonary aspergillosis is a form of asthma associated with a Type I, III, and IV allergic response to Aspergillus antigens. It presents clinically as asthma but is also associated with bronchiectasis, airway destruction, and permanent lung injury if inadequately treated. Treatment consists of anti-inflammatory agents such as corticosteroids. Antifungal agents may also be useful to lower the fungal antigen load. Aspergillomas grow in areas of devitalized lung. They may manifest as asymptomatic radiographic abnormalities. The concern is that they may lead to hemoptysis that can be life threatening. Definitive treatment is surgical resection, but this is often prohibited because these patients often have inadequate lung function to tolerate thoracic surgery. Other treatment options include azoles and percutaneous instillation of antifungals.
KEYWORDS
Aspergillus - aspergilloma - allergic bronchopulmonary aspergillosis - therapy - azoles - corticosteroids
REFERENCES
- 1 Stevens D A, Kan V L, Judson M A et al.. Practice guidelines for disease caused by Aspergillus . Clin Infect Dis. 2000; 30 696-709
- 2 Gerson S L, Talbot G H, Hurwitz S et al.. Prolonged granulocytopenia: the major risk factor fsor invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med. 1984; 100 345-351
- 3 Wald A, Leisenring W, van Burik J A et al.. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis. 1997; 175 1459-1466
- 4 Hibberd P L, Rubin R H. Clinical aspects of fungal infection in organ transplant recipients. Clin Infect Dis. 1994; 19(suppl 1) S33-S40
- 5 Denning D W, Follansbee S E, Scolaro M et al.. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med. 1991; 324 654-662
- 6 Stevens D A, Schwartz H J, Lee J Y et al.. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med. 2000; 342 756-762
- 7 Shah A, Khan Z U, Charturvedi S et al.. Allergic bronchopulmonary aspergillosis with coexistent aspergilloma: a long-term follow-up. J Asthma. 1989; 26 109-115
- 8 Judson M A. Allergic bronchopulmonary aspergillosis. Pulmonary Critical Care Update. 2003; 17 lesson 17
- 9 Vlahakis N E, Aksamit T R. Diagnosis and treatment of allergic bronchopulmonary aspergillosis. Mayo Clin Proc. 2001; 76 930-938
- 10 Schuyler M R. Allergic bronchopulmonary aspergillosis. Clin Chest Med. 1983; 4 15-22
- 11 Patterson R, Greenberger P A, Harris K E. Allergic bronchopulmonary aspergillosis [editorial]. Chest. 2000; 118 7-8
- 12 Hinson K F, Moon A J, Plummer N S. Bronchopulmonary aspergillosis. Thorax. 1952; 7 317-333
- 13 Greenberger P. Allergic bronchopulmonary aspergillosis. Clin Allergy Immunol. 2002; 16 449-468
- 14 Ricketti A J, Greenberger P A, Patterson R. Immediate-type reactions in patients with allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol. 1983; 71 541-545
- 15 Malo J L, Hawkins R, Pepys J. Studies in chronic allergic bronchopulmonary aspergillosis: clinical and physiological findings. Thorax. 1977; 32 254-261
- 16 Varkey B. Allergic bronchopulmonary aspergillosis: clinical perspectives. Immunol Allergy Clin North Am. 1998; 18 480-501
- 17 Graves T S, Fink J N, Patterson R, Kurup V P, Scanlon G T. A familial occurrence of allergic bronchopulmonary aspergillosis. Ann Intern Med. 1979; 91 378-382
- 18 Halwig M J, Kurup V P, Greenberger P A, Patterson R. A familial occurrence of allergic bronchopulmonary aspergillosis: a probable environmental source. J Allergy Clin Immunol. 1985; 76 55-59
- 19 Eaton T, Garrett J, Milne D, Frankel A, Wells A U. Allergic bronchopulmonary aspergillosis in an asthma clinic. Chest. 2000; 118 66-72
- 20 Patterson R, Greenberger P A, Halwig J M, Liotta J L, Roberts M. Allergic bronchopulmonary aspergillosis: natural history and classification of early disease by serologic and roentegographic studies. Arch Intern Med. 1986; 146 916-918
- 21 Basich J E, Graves T S, Nasir Baz M et al.. Allergic bronchopulmonary aspergillosis in corticosteroid-dependent asthmatics. J Allergy Clin Immunol. 1981; 68 98-102
- 22 Mrouch S, Spock A. Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Chest. 1994; 105 32-36
- 23 Neppmuceno I B, Esrig S, Moss R B. Allergic bronchopulmonary aspergillosis in cystic fibrosis. Chest. 1999; 115 364-370
- 24 McCarthy D S, Simon G, Hargreave F E. The radiological appearances in allergic bronchopulmonary aspergillosis. Clin Radiol. 1970; 21 366-375
- 25 Neeld D A, Goodman L R, Gurney J W et al.. Computerized tomography in the evaluation of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis. 1990; 142 1200-1205
- 26 Lynch D A. Imagine of asthma and allergic bronchopulmonary mycosis. Radiol Clin North Am. 1998; 36 129-142
- 27 Malo J P, Pepys J, Simon G. Studies in chronic allergic bronchopulmonary aspergillosis, II: Radiological findings. Thorax. 1977; 32 262-268
- 28 Phelan M S, Kerr I H. Allergic bronchopulmonary aspergillosis: the radiological appearance during long-term follow-up. Clin Radiol. 1984; 35 385-392
- 29 Ward S, Heyneman L, Lee M J et al.. Accuracy of CT in the diagnosis of allergic bronchopulmonary aspergillosis in asthmatic patients. AJR Am J Roentgenol. 1999; 173 937-942
- 30 Mitchell T AM, Hamilos D L, Lynch D A, Newell J D. Distribution and severity of bronchiectasis in allergic bronchopulmonary aspergillosis. J Asthma. 2000; 37 65-72
- 31 Crameri R, Hemmann S, Ismail C, Menz G, Blaser K. Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis. Int'l Immunol. 1998; 10 1211-1216
- 32 Banerjee B, Kurup V P, Greenberger P A, Johnson B D, Fink J N. Cloning and expression of Aspergillus fumigatus allergen Asp f 16 mediating both humoral and cell-mediated immunity in allergic bronchopulmonary asgergillosis (ABPA). Clin Exp Allergy. 2001; 31 761-770
- 33 Madan T, Banerjee B, Bhatnagar P K, Shah A, Sarma P U. Identification of 45kD antigen in immune complexes of patients of allergic bronchopulmonary aspergillosis. Mol Cell Biochem. 1997; 166 111-116
- 34 Crameri R. Molecular cloning of Aspergillus fumigatus allergens and their role in allergic bronchopulmonary aspergillosis. Chem Immunol. 2002; 81 73-93
- 35 Kurup V P, Grunig G, Knutsen A P, Murali P S. Cytokines in allergic bronchopulmonary aspergillosis. Res Immunol. 1998; 149 466-477
- 36 Kahn S, McClellan J S, Knutsen A P. Increased sensitivity to IL-4 in patients with allergic bronchopulmonary aspergillosis. Int'l Arch Allergy Immunol. 2000; 123 319-326
- 37 Chauhan B, Santiago L, Hutcheson P S et al.. Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol. 2000; 106 723-729
- 38 Cockrill B A, Hales C A. Allergic bronchopulmonary aspergillosis. Annu Rev Med. 1999; 50 303-316
- 39 Ricketti A J, Greenberger P A, Mintzer R A, Patterson R. Allergic bronchopulmonary aspergillosis. Arch Intern Med. 1983; 143 1553-1557
- 40 Elliott M W, Taylor J N. Allergic bronchopulmonary aspergillosis. Clin Exp Allergy. 1997; 27(suppl 1) 55-59
- 41 Greenberger P A, Patterson R. Allergic bronchopulmonary aspergillosis: model of bronchopulmonary disease with defined serologic, radiologic, pathologic and clinical findings from asthma to fatal destructive lung disease. Chest. 1987; 91(suppl) 165S-171S
- 42 Rosenberg M, Patterson R, Roberts M, Wang J. The assessment of immunologic and clinical changes occurring during corticosteroid therapy for allergic bronchopulmonary aspergillosis. Am J Med. 1978; 64 599-606
- 43 Greenberger P A, Patterson R. Diagnosis and management of allergic bronchopulmonary aspergillosis. Ann Allergy. 1986; 56 444-448
- 44 Sahn S A, Lakshminarayan S. Allergic bronchopulmonary penicillosis. Chest. 1973; 63 286-288
- 45 Hoshino H, Tagaki S, Kon H et al.. Allergic bronchopulmonary aspergillosis due to Aspergillus niger without bronchial asthma. Respiration. 1999; 66 369-372
- 46 Rajkumar D C. Evaluation of allergic bronchopulmonary aspergillosis in patients with and without central bronchiectasis. J Asthma. 2002; 39 473-477
- 47 Shah A, Panjabi C. Allergic bronchopulmonary aspergillosis: a review of a disease with a worldwide distribution. J Asthma. 2002; 39 273-289
- 48 Wark P AB, Gibson P G. Allergic bronchopulmonary aspergillosis: new concepts of pathogenesis and treatment. Respirology. 2001; 6 1-7
- 49 Capewell S, Chapman B J, Alexander F, Greening A P, Crompton G K. Corticosteroid treatment and prognosis in pulmonary eosinophilia. Thorax. 1989; 44 925-929
- 50 Safirstein B H, D'Sousa M F, Simon G, Tai E HC, Pepys J. Five-year follow-up of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis. 1973; 108 450-459
- 51 Middleton W G, Paterson I C, Grant I WB, Douglas A C. Asthmatic pulmonary eosinophilia: a review of 65 cases. Br J Dis Chest. 1977; 71 115-122
- 52 Wang J L, Patterson R, Roberts M, Ghory A C. The management of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis. 1979; 120 87-92
- 53 Fink J N. Allergic bronchopulmonary aspergillosis. Chest. 1985; 87(suppl) 81S-84S
- 54 Rosenberg M, Patterson R, Mintzer R, Cooper B J, Roberts M, Harris K E. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med. 1977; 86 405-414
- 55 McCarthy D S, Pepys J. Allergic bronchopulmonary aspergillosis: clinical immunology, II: Skin, nasal and bronchial tests. Clin Allergy. 1971; 1 415-432
- 56 Report to the Research Committee of the British Thoracic Society . Inhaled beclomethasone dipropionate in allergic bronchopulmonary aspergillosis. Br J Dis Chest. 1979; 73 349-356
- 57 Hilton A M, Chatterjee S S. Bronchopulmonary aspergillosis: treatment with beclomethasone dipropionate. Postgrad Med J. 1975; 51(suppl 4) 98-103
- 58 Seaton A, Seaton R A, Wightman A JA. Management of allergic bronchopulmonary aspergillosis. Q J Med. 1994; 87 529-537
- 59 Leon E E, Craig T J. Antifungals in the treatment of allergic bronchopulmonary aspergillosis. Ann Allergy Asthma Immunol. 1999; 82 511-517
- 60 Germand P, Tuchais E. Allergic bronchopulmonary aspergillosis treated with itraconazole. Chest. 1995; 107 883
- 61 Pacheco A, Martin J A, Cuevas M. Serologic response to itraconazole in allergic bronchopulmonary aspergillosis. Chest. 1993; 103 980-981
- 62 De Beule K, De Doncher P, Cauwenbergh G et al.. The treatment of aspergillosis and aspergilloma with itraconazole, clinical results and open label study (1982-1987). Mycoses. 1988; 31 476-485
- 63 Chabasse D, Tuchais E, Bouchara J P, De Gentile L, Tuchais N. Efficacite de l'itraconazole dans le traitment de l'aspergillosis broncho-pulmonare allergique (ABPA), a propos de 2 observations. Bull Soc Fr Myc Med. 1990; 19 271-275
- 64 Nikaido Y, Nagata N, Yamamoto T, Yoshii C, Ohmori H, Kido N. A case of allergic bronchopulmonary aspergilosis successfully treated with itraconazole. Respir Med. 1998; 92 118-119
- 65 Matsuzaki Y, Jimi T, Tao Y, Takada S, Miyazaki N. Allergic bronchopulmonary aspergillosis successfully treated with itraconazole (Japanese). Nihon Kyobu Shikkan Gakkai Zasshi. 1997; 35 352-356
- 66 Salez F, Brichet A, Desurmont S, Grosbois J-M, Wallert B, Tuonnel A-B. Effects of itraconazole therapy in allergic bronchopulmonary aspergillosis. Chest. 1999; 116 1665-1668
- 67 Mannes G P, van der Heide S, van Aalderen W M, Gerritsen J. Itraconazole and allergic bronchopulmonary aspergillosis in two brothers with cystic fibrosis. Lancet. 1993; 341 492
- 68 Lebeau B, Pelloux H, Pinel C et al.. Itraconazole in the treatment of aspergillosis: a study of 16 cases. Mycoses. 1994; 37 171-179
- 69 Denning D W, Van Wye J E, Lewiston N J, Stevens D A. Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole. Chest. 1991; 100 813-819
- 70 Measaki S, Iwakawa J, Higashiyama Y et al.. Antifungal activity of a new triazole, voriconazole (UK-109496), against clinical isolates of Aspergillus spp. J Infect Chemother. 2000; 6 101-103
- 71 Pfaller M A, Messer S A, Hollis R J, Jones R N. Sentry Participants Group. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY antimicrobial surveillance program, 2000. Antimicrob Agents Chemother. 2002; 46 1032-1037
- 72 National Asthma Education and Prevention Program .Expert panel report, 2: Guidelines for the diagnosis and management of asthma; clinical practice guidelines, component 3. Bethesda, MD; National Institutes of Health 1997 Publication no. 97-405
- 73 Radin R C, Greenberger P A, Patterson R, Ghory A. Mould counts and exacerbations of allergic bronchopulmonary aspergillosis. Clin Allergy. 1983; 13 271-275
- 74 Hanley-Lopez J, Clement L T. Allergic bronchopulmonary aspergillosis in cystic fibrosis. Curr Opin Pulm Med. 2000; 6 540-544
- 75 Mastella G, Rainisio M, Harms H K et al.. Epidemiologic Registry of Cystic Fibrosis: allergic bronchopulmonary aspergillosis in cystic fibrosis: a European epidemiological study. Eur Respir J. 2000; 16 464-471
- 76 Geller D E, Kaplowitz H, Light M, Colin A A. Epidemiologic Study of Cystic Fibrosis: allergic bronchopulmonary aspergillosis in cystic fibrosis: reported prevalence, regional distribution, and patient characteristics. Chest. 1999; 116 639-646
- 77 Hutcheson P S, Rejent A J, Slavin R G. Variability in parameters of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. J Allergy Clin Immunol. 1991; 88 390-394
- 78 Moss R B. Allergic bronchopulmonary aspergillosis. Clin Rev Allergy Immunol. 2002; 23 87-104
- 79 Skov M, Hoiby N, Koch C. Itraconazole treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Allergy. 2002; 57 723-728
- 80 Miller P W, Hamosh A, Macek M et al.. Cystic fibrosis transmembrane conductance regulator (CFTR) mutations in allergic bronchopulmonary aspergillosis. Am J Hum Genet. 1996; 59 45-51
- 81 Marchand E, Verellen-Dumoulin C, Maresse M et al.. Frequency of cystic fibrosis transmembrane conductance regulator gene mutations and 5T allele in patients with allergic bronchopulmonary aspergillosis. Chest. 2001; 119 762-767
- 82 Eaton T E, Weiner Miller P, Garrett J E, Cutting G R. Cystic fibrosis transmembrane conductance regulator gene mutations: do they play a role in the etiology of allergic bronchopulmonary aspergillosis?. Clin Exp Allergy. 2002; 32 756-761
- 83 Fraser R, Pare J, Pare P et al.. Diagnosis of diseases of the chest. 3rd ed. Philadelphia; WB Saunders 1998
- 84 British Tuberculosis and Thoracic Association . Aspergilloma and residual tuberculosis cavities: the result of a resurvey. Tubercle. 1970; 51 227-245
- 85 Libshitz H I, Atkinson G W, Israel H L. Pleural thickening as a manifestation of Aspergillus superinfection. AJR Am J Roentgenol. 1974; 120 883-886
- 86 Glimp R A, Bayer A S. Pulmonary aspergilloma: diagnostic and therapeutic considerations. Arch Intern Med. 1983; 143 303-308
- 87 Rafferty P, Biggs B, Crompton G K et al.. What happens to patients with pulmonary aspergilloma?. Thorax. 1983; 38 579-583
- 88 Andrews C P, Weiner M H. Aspergillus antigen detection in bronchoalveolar lavage fluid from patients with invasive aspergillosis and aspergilloma. Am J Med. 1982; 73 372-380
- 89 Smith R L, Morelli M J, Aranda C P. Pulmonary aspergilloma diagnosed by fiberoptic bronchoscopy. Chest. 1987; 92 948-949
- 90 Severo L C, Londero A T, Picon P D, Rizzon C F, Tarasconi J C. Petriellidium boydii fungus ball in a patient with active tuberculosis. Mycopathologia. 1982; 77 15-17
- 91 Goldberg B. Radiological appearances in pulmonary aspergillosis. Clin Radiol. 1962; 13 106-114
- 92 Irwin A. Radiology of the aspergilloma. Clin Radiol. 1966; 18 432-438
- 93 Kathuria S K, Rippon J. Non-Aspergillus aspergilloma. Am J Clin Pathol. 1982; 78 870-873
- 94 McCarthy D S, Peppys J. Pulmonary aspergilloma: clinical immunology. Clin Allergy. 1973; 3 57-70
- 95 Wollschlager C, Kahn F. Aspergillomas complicating sarcoidosis: a prospective study of 100 patients. Chest. 1984; 86 585-588
- 96 Torpoco J O, Yousuffuddin M, Pate J W. Aspergilloma within a malignant pulmonary cavity. Chest. 1976; 69 561-563
- 97 Makker H, McConnochie K, Gibbs A R. Postirradiation pulmonary fibrosis complicated by aspergilloma and bronchocentric granulomatosis. Thorax. 1989; 44 676-677
- 98 Solit R W, McKeown J J, Smullens S. The surgical implications of intracavitary mycetomas (fungus balls). J Thorac Cardiovasc Surg. 1971; 62 411-422
- 99 Joynson D HM. Pulmonary aspergilloma. Br J Clin Pract. 1977; 31 207-216
- 100 Schwartz J, Baum G L, Straub M. Cavitary histoplasmosis complicated by fungus ball. Am J Med. 1961; 31 692-700
- 101 Sarosi G A, Silberfarb P M, Saliba N A et al.. Aspergillomas occurring in blastomycotic cavities. Am Rev Respir Dis. 1971; 104 581-584
- 102 Haslock I. Ankylosing spondylitis. Baillieres Clin Rheumatol. 1993; 7 99-115
- 103 Bruce R A. A case of pulmonary aspergillosis. Tubercle. 1957; 38 203-205
- 104 Flye M W, Sealy W C. Pulmonary aspergilloma: a report of its occurrence in two patients with cyanotic heart disease. Ann Thorac Surg. 1975; 20 196-203
- 105 Aslam P A, Eastridge C E, Hughes F A. Aspergillosis of the lung: an 18-year experience. Chest. 1971; 59 28-32
- 106 Addrizzo-Harris D J, Harkin T J, McGuinness G et al.. Pulmonary aspergilloma and AIDS. Chest. 1997; 111 612-618
- 107 Shah A, Khan Z U, Chaturvedi S, Malik G B, Randhawa H S. Concomitant allergic Aspergillus sinusitis and allergic bronchopulmonary aspergillosis associated with familial occurrence allergic bronchopulmonary aspergillosis. Ann Allergy. 1990; 64 507-512
- 108 Pimentel J C. Pulmonary calcification in the tumor-like form of pulmonary aspergillosis: pulmonary aspergilloma. Am Rev Respir Dis. 1966; 94 208-216
- 109 Campbell M J, Clayton Y M. Bronchopulmonary aspergillosis: a correlation of clinical and laboratory findings in 272 patients investigated for bronchopulmonary aspergillosis. Am Rev Respir Dis. 1964; 89 186-196
- 110 Hilvering C, Stevens E AM, Orie N GM. Fever in aspergillus mycetoma. Thorax. 1970; 25 19-24
- 111 Binder R E, Faling L J, Putatch R D et al.. Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity. Medicine. 1982; 60 109-124
- 112 Faulkner S L, Vernon R, Brown P P et al.. Hemoptysis and pulmonary aspergilloma: operative versus nonoperative treatment. Ann Thorac Surg. 1978; 25 389-392
- 113 Lewis M M, Mortelliti M P, Yeager Jr H, Tsou E. Clinical bronchiectasis complicating pulmonary sarcoidosis: a case series of seven patients. Sarcoidosis Vasc Diffuse Lung Dis. 2002; 19 154-159
- 114 Tomlinson J, Sahn S A. Aspergilloma in sarcoidosis and tuberculosis. Chest. 1987; 92 505-508
- 115 Tomee J, VanDer Werf T, Latge J et al.. Serologic monitoring of disease and treatment in a patient with pulmonary aspergilloma. Am J Respir Crit Care Med. 1995; 151 199-204
- 116 Kauffman C. Quandary about treatment of aspergillomas persists. Thorax. 1996; 347 1640
- 117 Daly R C, Pairolero P C, Piehler J M et al.. Pulmonary aspergilloma: results of treatment. J Thorac Cardiovasc Surg. 1986; 92 981-988
- 118 Soltanzadeh H, Wychulis A R, Sadr F et al.. Surgical treatment of aspergilloma. Ann Surg. 1977; 186 13-16
- 119 Jewkes J, Kay P H, Paneth M et al.. Pulmonary aspergilloma: analysis of prognosis in relation to hemoptysis and survey of treatment. Thorax. 1983; 38 572-578
- 120 Garvey J, Crastnopol P, Weisz D et al.. The surgical treatment of pulmonary aspergillomas. J Thorac Cardiovasc Surg. 1977; 74 642-647
- 121 Israel H L, Lenchner G S, Atkinson G W. Sarcoidosis and aspergilloma: the role of surgery. Chest. 1982; 82 430-432
- 122 Kaestel M, Meyer W, Mittelmeier H O et al.. Pulmonary aspergilloma: clinical findings and surgical treatment. Thorac Cardiovasc Surg. 1999; 47 340-345
- 123 Massard G, Roeslin N, Wihlm J M et al.. Pleuropulmonary aspergilloma: clinical spectrum and results of surgical treatment. Ann Thorac Surg. 1992; 54 1159-1164
- 124 Conlan A A, Abramor E, Moyes D G. Pulmonary aspergilloma: indications for surgical intervention: an analysis of 22 cases. S Afr Med J. 1987; 71 285-288
- 125 Battaglini J W, Murray G F, Kaegy B A et al.. Surgical management of symptomatic pulmonary aspergilloma. Ann Thorac Surg. 1985; 39 512-516
- 126 Kay P H. Surgical management of pulmonary aspergilloma [editorial]. Thorax. 1997; 52 753-754
- 127 Chen J C, Chang Y L, Luh S P et al.. Surgical treatment for pulmonary aspergilloma: a 28-year experience. Thorax. 1997; 52 810-813
- 128 Chatzimichalis A, Massard G, Kessler R et al.. Bronchopulmonary aspergilloma: a reappraisal. Ann Thorac Surg. 1998; 65 927-929
- 129 Oakley R E, Petrou M, Goldstraw P. Indications and outcome of surgery for pulmonary aspergilloma. Thorax. 1997; 52 813-815
- 130 Giron J M, Poey C G, Fajadet P P et al.. Inoperable pulmonary aspergilloma: percutaneous CT-guided injection with glycerin and amphotericin B paste in 15 cases. Radiology. 1993; 188 825-827
- 131 Jackson M, Flower C DR, Shneerson J M. Treatment of symptomatic pulmonary aspergillomas with intracavitary instillation of amphotericin B through an indwelling catheter. Thorax. 1993; 48 928-930
- 132 Munk P L, Vellet A D, Rankin R N et al.. Intracavitary aspergilloma: transthoracic percutaneous injection of amphotericin B solution. Radiology. 1993; 188 821-823
- 133 Lee K S, Kim H T, Kim Y H et al.. Treatment of hemoptysis in patients with cavitary aspergilloma of the lung: value of percutaneous instillation of amphotericin B. AJR Am J Roentgenol. 1993; 161 727-731
- 134 Klein J S, Fang K, Chang M C. Percutaneous transcatheter treatment of an intracavitary aspergilloma. Cardiovasc Intervent Radiol. 1993; 16 321-324
- 135 Yamada H, Kohno S, Koga H et al.. Topical treatment of pulmonary aspergilloma by antifungals. Chest. 1993; 103 1421-1425
- 136 Hargis J L, Bone R C, Stewart J et al.. Intracavitary amphotericin B in the treatment of symptomatic pulmonary aspergillomas. Am J Med. 1980; 68 389-394
- 137 Rumbak M, Kohler G, Eastrige C et al.. Topical treatment of life-threatening hemoptysis from aspergillomas. Thorax. 1996; 51 253-255
- 138 Guleria R, Gupta D, Jindal S K. Treatment of pulmonary aspergilloma by endoscopic intracavitary instillation of ketoconazole. Chest. 1993; 103 1301-1302
- 139 Kaplan J, Johns C J. Mycetomas in pulmonary sarcoidosis: nonsurgical management. J Hopkins Med J. 1979; 145 157-161
- 140 Remy J, Arnaud A, Fardou H et al.. Treatment of hemoptysis by embolization of bronchial arteries. Radiology. 1977; 122 33-37
- 141 Uflacker R, Kaemmerer A, Neves C et al.. Management of massive hemoptysis by bronchial artery embolization. Radiology. 1983; 146 627-634
- 142 Falkson C, Sur R, Pacella J. External beam radiotherapy: a treatment option for massive hemoptysis caused by mycetoma. Clin Oncol. 2002; 14 233-235
- 143 Shneerson J M, Emerson P A, Phillips R H. Radiotherapy for massive hemoptysis from an aspergilloma. Thorax. 1980; 35 953-954
- 144 Mikami M, Nakamura S, Kawakami M. Pulmonary aspergilloma successfully treated with long-term intermittent inhalation therapy with miconazole. Intern Med. 1993; 32 247-250
- 145 Hammerman K H, Sarosi G A, Tosh F E. Amphotericin B in the treatment of saprophytic forms of pulmonary aspergillosis. Am Rev Respir Dis. 1974; 109 57-62
- 146 Van Cutsem J, Van Gerven F, Vam De Ven M A et al.. Itraconazole, a new triazole that is orally active in aspergillosis. Antimicrob Agents Chemother. 1984; 26 615-619
- 147 Jennings T S, Hardin T C. Treatment of aspergillosis with itraconazole. Ann Pharmacother. 1993; 27 1206-1211
- 148 Campbell J H, Winter J H, Richardson M D et al.. Treatment of pulmonary aspergilloma with itraconazole. Thorax. 1991; 46 839-841
- 149 Dupont B. Itraconazole therapy in aspergillosis: study in 49 patients. J Am Acad Dermatol. 1990; 23 607-614
- 150 Impens N, De Greve J, DeBeule K et al.. Oral treatment with itraconazole of aspergilloma in cavitary lung cancer. Eur Respir J. 1990; 3 837-839
- 151 Tsubura E. Multicenter clinical trial of itraconazole in the treatment of pulmonary aspergilloma. Kekkaku. 1997; 72 557-564
- 152 Judson M A. Diagnosis and management of aspergilloma. Pulmonary Critical Care Update. 2002; 15 1-14
Marc A JudsonM.D.
Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina
96 Jonathan Lucas St.
Charleston, SC 29425
Email: judsonma@MUSC.edu